This new clinical trial, a Phase 2 without a control arm, launched in November 2012 and is recruiting 50 new patients. The transplant would be performed at the Texas Oncology-Amarillo Cancer Center. There are a few restrictions: no PPMSers, you must have failed two treatments, you must still be able to walk 100 meters without aid (EDSS 5.5), be 60 or younger, and you need to show evidence of two relapses in the past year (relapse and/or MRI changes). Details at the link.
A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant for Multiple Sclerosis That Failed at Least Two Lines of Therapy
http://clinicaltrials.gov/ct2/show/N...m+cell&rank=19
A Phase II Study of High Dose Chemotherapy With Autologous Hematopoietic Progenitor Cell Transplant for Multiple Sclerosis That Failed at Least Two Lines of Therapy
http://clinicaltrials.gov/ct2/show/N...m+cell&rank=19